Obermatt
See Similar Stocks →

Ildong Holdings

KSC:000230 · KR7000230003
PharmaceuticalsSmall

360

83
Medium confidence — indicative
Profit price41
Owner Earnings Yield91
Dividend Yield1
Price/Sales100
EV / Gross Profit88
Price/Book81
Return on Capital72
Cash Return on Capital84
Return on Equity87
EBIT Margin68
Gross Profitability67
Cash Conversion56
Accruals50
Owner Earnings Margin84
Sales growth50
Profit Growth91
Long-Term EPS Growth95
Owner Earnings Growth37
Reinvestment25
Price momentum78
Debt load28
Refinancing80
Debt Payback41
Liquidity22
Analyst ratings—
Expectations trend—
Market mood33
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Ildong Holdings clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Websitem.ildongholdings.com
ISINKR7000230003
Last UpdateApr 2, 2026
Indices
KOSPI (South Korea)
Themes
NutraceuticalObesityOncology

Description

Analysis

Quality compounder

Ildong Holdings Co., Ltd. is a quality compounder: a well-run business trading at a price that reflects what it is worth.

The price is attractive. You pay 2.3× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone.

The trajectory is moderate and the balance sheet is stretched. The company scores 12/20 on our value-creation score: creating some value.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
41
2026

All-time high

41

Jun 2026

All-time low

25

Mar 2026

Average rank

33

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
100
—
—
—
Price/Earnings
89
—
—
—
Price/Book
81
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
82
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Ildong Holdings with its peers
Yungjin Pharm
KSC:003520
34
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Dongwha Pharm
KSC:000020
44
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Whanin Pharm
KSC:016580
99
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Ilsung IS
KSC:003120
59
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Samsung Pharm
KSC:001360
—
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Hana Pharm
KSC:293480
88
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →